Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
University of Washington
University of Washington
University of Washington
Alliance for Clinical Trials in Oncology
Gustave Roussy, Cancer Campus, Grand Paris
University of Washington
M.D. Anderson Cancer Center
Medical College of Wisconsin
Universität des Saarlandes
M.D. Anderson Cancer Center
Thomas Jefferson University
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
University of Washington
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Northwestern University
PETHEMA Foundation
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
M.D. Anderson Cancer Center
German High-Grade Non-Hodgkin's Lymphoma Study Group
University of Wisconsin, Madison
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Hoag Memorial Hospital Presbyterian
Northern Italy Leukemia Group
St. Jude Children's Research Hospital